Warfarin Use and Increased Mortality in End Stage Renal Disease

BACKGROUND: Controversy exists regarding the benefits and risks of warfarin therapy in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients. In this study, we assessed mortality and cardiovascular outcomes associated with warfarin treatment in patients with stage 3–5 CKD and ESRD...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Nephrol
Main Authors: Lin, Mark C., Streja, Elani, Soohoo, Melissa, Hanna, Medhat, Savoj, Javad, Kalantar-Zadeh, Kamyar, Lau, Wei Ling
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657430/
https://ncbi.nlm.nih.gov/pubmed/28910806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481207
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares